- $2.68bn
- $4.12bn
- CNY34.26bn
- 58
- 98
- 63
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 47,761 | 52,031 | 61,866 | 58,116 | 34,261 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 27,205 | 31,655 | 37,939 | 43,867 | 32,407 |
Operating Profit | 20,556 | 20,376 | 23,927 | 14,249 | 1,854 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19,434 | 17,910 | 23,400 | 13,013 | 1,645 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13,317 | 12,276 | 16,709 | 8,775 | 1,034 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13,332 | 12,354 | 16,804 | 8,699 | 887 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 13,332 | 12,354 | 16,804 | 8,699 | 887 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 44 | 43.9 | 51.7 | 7.83 | 0.79 |